KTOV Research and Charts

KTOV - Kitov Pharma Ltd ADR (Healthcare: Biotechnology)

Projected Earnings Date: 0000-02-29 (Delayed quote data 2025-01-02)

Last 4.59	Change ⇓ -0.10 (-2.13%)	Volume 140,706
	Open 4.95	High 4.95	Low 4.28

8EMA (Daily) 4.28	40EMA (Daily) 3.87	50EMA (Daily) 3.77	STO (Daily) 65.642	MACD Hist (Daily) 0.139
8EMA (Weekly) 3.888	40EMA (Weekly) 2.47	50EMA (Weekly) 2.27	STO (Weekly) 24.276	MACD Hist (Weekly) 0.105


Company Profile
Kitov Pharma Ltd is development stage biopharmaceutical company. It focuses on the development of KIT-302, a combination drug for the simultaneous treatment of two clinical conditions pain caused by osteoarthritis and hypertension; and NT219 which is a fixed-dose combination of two drug products that treat osteoarthritis pain and hypertension simultaneously. The company operates its business in Israel.

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.